Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 studyJean-Luc Van Laethem,Ivan Borbath,Hans Prenen,Karen Paula Geboes,Aurélien Lambert,Emmanuel Mitry,Philippe Alexandre Cassier,Jean-Frédéric Blanc,Lorenzo Pilla,Jaime Feliu Batlle,Mercedes Rodriguez Garrote,Roberto Antonio Pazo-Cid, Inmaculada Gallego,Karin Enell Smith,Peter Ellmark,Yago Pico de Coaña,Sumeet Vijay Ambarkhane,Teresa MacarullaThe Lancet Oncology(2024)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要